Highlights
- •OS AID has been shown to improve clinical outcomes and quality of life.
- •This is the first study to identify the most common barriers to uptake of OS AID among those currently not using such a system.
- •The findings highlight the implications of inequalities in access to OS AID and how they might be addressed.
Abstract
Aims
Social and technical trends are empowering people with diabetes to co-create or self-develop
medical devices and treatments to address their unmet healthcare needs, for example,
open-source automated insulin delivery (AID) systems. This study aims to investigate
the perceived barriers towards adoption and maintaining of open-source AID systems.
Methods
This is a multinational study based on a cross-sectional, retrospective web-based
survey of non-users of open-source AID. Participants (n = 129) with type 1 diabetes
from 31 countries were recruited online to elicit their perceived barriers towards
building and maintaining of an open-source AID system.
Results
Sourcing the necessary components, lack of confidence in one's own technology knowledge
and skills, perceived time and energy required to build a system, and fear of losing
healthcare provider support appear to be major barriers towards the uptake of open-source
AID.
Conclusions
This study identified a range of structural and individual-level barriers to uptake
of open-source AID. Some of these individual-level barriers may be overcome over time
through the peer support of the DIY online community as well as greater acceptance
of open-source innovation among healthcare professionals. The findings have important
implications for understanding the possible wider diffusion of open-source diabetes
technology solutions in the future.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Diabetes Research and Clinical PracticeAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A patient-designed do-it-yourself mobile technology system for diabetes.JAMA. 2016; : 1447https://doi.org/10.1001/jama.2016.1903
- Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: online survey and analysis of self-reported clinical outcomes.JMIR Mhealth Uhealth. 2019; 7: e14087
- DIY artificial pancreas systems: here to stay?.Pract diabetes. 2019; 36: 63-68
- Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.Lancet Diabetes Endocrinol. 2022 Jan 1; 10: 58-74
- Open-source automated insulin delivery in type 1 diabetes.N Engl J Med. 2022; 387: 869-881
- Why #WeAreNotWaiting—motivations and self-reported outcomes among users of open-source automated insulin delivery systems: multinational survey.J Med Internet Res. 2021; 23: e25409
- Open source closed-loop insulin delivery systems: a clash of cultures or merging of diverse approaches?.J Diabetes Sci Technol. 2018; 12: 1223-1226
- Do-it-yourself automated insulin delivery: a leading example of the democratization of medicine.J Diabetes Sci Technol. 2020; 14: 878-882
- How Adults with Type 1 diabetes are navigating the challenges of open-source artificial pancreas systems: a qualitative study.Diabetes Technol Ther. 2021; https://doi.org/10.1089/dia.2020.0652
- 78-LB: Detailing the Experiences of People with Diabetes Using Do-It-Yourself Artificial Pancreas Systems—Qualitative Analysis of Responses to Open-Ended Items in an International Survey.Diabetes. 2019; : 68https://doi.org/10.2337/db19-78-LB
- Learning to close the loop.Diabetes. 2018; : 67https://doi.org/10.2337/db18-983-P
Braune K, Gajewska KA, Thieffry A, Lewis DM, Froment T, O'Donnell S, Speight J, Hendrieckx C, Schipp J, Skinner T, Langstrup H, Tappe A, Raile K, Cleal B. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey. J Med Internet Res. 2021 Jun 7;23(6):e25409. doi: 10.2196/25409.
- Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study.Acta Diabetol. 2021; 58: 93-105
- Do-it-yourself artificial pancreas systems in type 1 diabetes: perspectives of two adult users, a caregiver and three physicians.Diabetes Ther. 2019; 10: 1553-1564
- Do-It-Yourself (DIY) closed loop systems: perspectives of an endocrinologist.J Diabetes Sci Technol. 2020; 14: 1104-1106
- Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study.BMC Endocr Disord. 2020; 20: 92
- A real-world prospective study of the safety and effectiveness of the loop open source automated insulin delivery system.Diabetes Technol Ther. 2020; https://doi.org/10.1089/dia.2020.0535
- Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: a retrospective analysis.Pediatr Diabetes. 2021; https://doi.org/10.1111/pedi.13190
- Access issues in diabetes technology: the case of do-it-yourself artificial pancreas systems.Diabetes Technol Ther. 2020; : 22https://doi.org/10.1089/dia.2020.2525.abstracts
- “Your wealth is your health”: the fundamental causes of inequalities in diabetes management outcomes: a qualitative analysis.Sociol Health Illn. 2020; 42: 1626-1641
- Prescribing unapproved medical devices? the case of DIY artificial pancreas systems.Med Law Int. 2021; 21: 42-68
- The DIY artificial pancreas system: an ethical dilemma for doctors.Diabet Med. 2020; https://doi.org/10.1111/dme.14270
- Using a Do-It-Yourself Artificial Pancreas: perspectives from Patients and Diabetes Providers.J Diabetes Sci Technol. 2020; 14: 860-867
- Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.Frontiers in Clin Diabetes and Healthcare. 2022; : 3https://doi.org/10.3389/fcdhc.2022.876511
- HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: a deeper dive into the influence of technology and socioeconomic status on HbA1c in the T1D Exchange Clinic Registry Findings.Diabetes Technol Ther. 2020; 22: 645-650
- Barriers to technology use and endocrinology care for underserved communities with type 1 Diabetes.Diabetes Care. 2021; https://doi.org/10.2337/dc20-2753
- Stratified users and technologies of empowerment: theorising social inequalities in the use and perception of diabetes self-management technologies.Sociol Health Illn. 2020; 42: 862-876
- The diffusion of innovative diabetes technologies as a fundamental cause of social inequalities in health. 42. The Nord‐Trøndelag Health Study, Norway. Sociology of Health & Illness, 2020: 1548-1565
- DIY artificial pancreas: a narrative of the first patient and the physicians’ experiences from India.Diabetes Metab Syndr. 2021; : 615-620https://doi.org/10.1016/j.dsx.2021.02.033
- Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.J Diabetes Sci Technol. 2019; (1932296819894296)
- User and healthcare professional perspectives on do-it-yourself artificial pancreas systems: a need for guidelines.J Diabetes Sci Technol. 2020; (1932296820957728)
- Bodies in Balance: Tracking Type. 2022; 28: 89-113https://doi.org/10.1177/1357034X2211091
Article info
Publication history
Published online: December 26, 2022
Accepted:
December 21,
2022
Received in revised form:
December 13,
2022
Received:
November 9,
2022
Identification
Copyright
© 2022 Published by Elsevier B.V.
